Vocxi Health
4 known investors
Vocxi Health develops MyBreathPrint, a noninvasive breath-analysis system that uses a sensor array to detect volatile organic compounds at parts-per-billion levels and connect them to disease patterns, with an initial focus on early lung cancer detection. Results are uploaded to a cloud platform and delivered to a physician for analysis, intended for use in doctors' offices and eventually at home.